Dr. Frank Mathias is the Chief Executive Officer of Oxford Biomedica (OXB), a leader in the cell and gene therapy space. With extensive experience from prior CEO roles at Rentschler Biopharma and Medigene AG, he focuses on client-centric strategies, global expansion, and innovation in viral vector manufacturing.
He believes strategic alliances are essential for navigating future challenges in the biopharmaceutical industry, fostering partnerships to bring complex products to patients faster.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dr. has no verified education history
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.